Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cerebrovascular Diseases(Electronic Edition) ›› 2020, Vol. 14 ›› Issue (04): 217-220. doi: 10.11817/j.issn.1673-9248.2020.04.006

Special Issue:

• Clinical Research • Previous Articles     Next Articles

The effect of urinary kallidinogenase on SDF-1, ET-1, VEGF, cognitive function in patients with acute cerebral infarction

Chunying Ou1, Chuanling Li1, Jing Guo1(), Xiaobin Li1, Xiaolei An1, Ke Xu1   

  1. 1. Department of Neurology, Xuzhou Central Hospital, Xuzhou 221000, China
  • Received:2020-03-20 Online:2020-08-01 Published:2020-08-01
  • Contact: Jing Guo
  • About author:
    Corresponding author: Guo Jing, Email:

Abstract:

Objective

To investigate the effect of urinary kallidinogenase on stromal cell-derived factor-1 (SDF-1), vascular endothelin-1 (ET-1), vascular endothelial growth factor (VEGF) and cognitive function in patients with acute cerebral infarction.

Methods

Sixty patients with acute cerebral infarction hospitalized in Xuzhou Central Hospital from January 2017 to May 2018 were randomly enrolled in control group and treatment group, 30 cases in each group. The control group received routine neurological medicine for acute cerebral infarction, and the treatment group received additional use of urinary kallidinogenase 0.15 PNA for injection. The course of treatment is 14 days. The concentration of SDF-1, ET-1, VEGF and MoCA score were measured before treatment and 14 days after treatment. The MoCA score was evaluated again 3 months after treatment.

Results

There were no significant differences in concentration of SDF-1, ET-1, VEGF, and MoCA scores between the two groups. After 14 days of treatment, the concentration of ET-1 in the treatment group[(57.33±14.61) pg/L] was significantly lower than that in the control group[(65.17±12.88) pg/L, P=0.031]. SDF-1[(4024.10±379.30) pg/ml], VEGF[(316.38±84.27) ng/ml] in the treatment group were significantly higher than SDF-1[(3171.60±337.00) pg/ml, P<0.001], VEGF[(250.26±93.56) ng/ml, P=0.006] in the control group three months after treatment, the MoCA score (26.60±1.75) was significantly higher than the control group(25.07±3.60, P=0.040).

Conclusion

Urinary kallidinogenase reduced the concentration of ET-1 in patients with acute cerebral infarction and increased the level of SDF-1 and VEGF, and possibly improving the cognitive function of patients with acute cerebral infarction.

Key words: Urinary kallidinogenase, Stromal cell-derived factor-1, Endothelin-1, Vascular endothelial growth factor, Cognitive function

京ICP 备07035254号-20
Copyright © Chinese Journal of Cerebrovascular Diseases(Electronic Edition), All Rights Reserved.
Tel: 01082266456, 15611963912, 15611963911 E-mail: zhnxgbzzbysy@163.com
Powered by Beijing Magtech Co. Ltd